Beyond Air® Schedules Third Fiscal Quarter 2022 Financial Results Conference Call and Webcast
January 27, 2022
Beyond Air® Provides Regulatory Update for LungFit® PH
December 9, 2021
Beyond Air® Expands Leadership Team with the Appointment of Dr. Andrew Colin to Chief Medical Officer
December 1, 2021
Beyond Air® Announces $30 Million of Committed Capital in Previously Reported Beyond Cancer™ Private Placement
November 18, 2021
Beyond Air® Reports Financial Results for the Second Quarter of Fiscal Year 2022
November 11, 2021
Beyond Air® Announces Formation of Beyond Cancer™, a New Private Company Dedicated to Oncology Utilizing Ultra-High Concentration Nitric Oxide to Treat Solid Tumors
November 4, 2021
Beyond Air® to Participate in the Piper Sandler 33rd Annual Virtual Healthcare Conference
November 2, 2021
Beyond Air® Schedules Second Fiscal Quarter 2022 Financial Results Conference Call and Webcast
October 25, 2021
Beyond Air® Reports Positive Interim Results for LungFit® GO Pilot Study Using High Concentration Inhaled Nitric Oxide Self-Administered, At-Home for Nontuberculous Mycobacterial Lung Disease
October 20, 2021
Beyond Air® Provides Global Regulatory Update for LungFit® PH
September 21, 2021

Sign up for updates from Beyond Air, Inc.

Unsubscribe from all email communications. Unsubscribe